(R,E)-7-(4-(4-Fluorophenyl)-2-(2-hydroxy-N,2-dimethylpropylsulfonamido)-6-isopropylpyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoate (Rosuvastatin Impurity)
| CAS No. | : NA |
| Mol F. | : C25H31FN3O7S.1/2Ca |
| Mol W. | : 556.63 |
| Cat No. | : SA12143 |
- Description
- Quick Enquiry / RFQ
Description
| Product Name | (R,E)-7-(4-(4-Fluorophenyl)-2-(2-hydroxy-N,2-dimethylpropylsulfonamido)-6-isopropylpyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoate (Rosuvastatin Impurity) |
| Synonyms | (6E)-7-(4-(4-Fluorophenyl)-2-[[(2-hydroxy-2-methylpropyl)sulfonyl)](methyl)amino]-6- isopropylpyrimidine-5-yl}(3R, 5S)-3,5-dihydroxyhept-6-enoic acid] Calcium Salt |
| Related API | Rosuvastatin |
| Category | Impurities |
(R,E)-7-(4-(4-Fluorophenyl)-2-(2-hydroxy-N,2-dimethylpropylsulfonamido)-6-isopropylpyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoate (Rosuvastatin Impurity) product with CAS: NA is related to Rosuvastatin. It is also known with other names such as (6E)-7-(4-(4-Fluorophenyl)-2-[[(2-hydroxy-2-methylpropyl)sulfonyl)](methyl)amino]-6- isopropylpyrimidine-5-yl}(3R, 5S)-3,5-dihydroxyhept-6-enoic acid] Calcium Salt; . (R,E)-7-(4-(4-Fluorophenyl)-2-(2-hydroxy-N,2-dimethylpropylsulfonamido)-6-isopropylpyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoate (Rosuvastatin Impurity) used for Abbreviated New Drug Application (ANDA) & DMF filing to FDA, toxicity study of respective drug formulation, Quality Control (QC), and analytical studies during commercial production of Rosuvastatin.
Product quantity / packs as per your requirement, just let us know!
Please contact us or email us at [email protected]
